COVID-19-induzierte Koagulopathien und thromboembolische Manifestationen

CLINICAL ISSUE: Clinically, COVID-19 (coronavirus disease 2019) is increasingly seen as a systemic disease associated with multiorgan involvement through a hypercoagulatory condition in the sense of vasculopathy. STANDARD TREATMENT: Treatment with antiplatelet drugs or heparins appears to be indicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sedlaczek, O., Wagner, W., Dempfle, C. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
Leitthema
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461592/
https://www.ncbi.nlm.nih.gov/pubmed/34559248
http://dx.doi.org/10.1007/s00117-021-00901-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461592/
https://www.ncbi.nlm.nih.gov/pubmed/34559248
http://dx.doi.org/10.1007/s00117-021-00901-8

Ejemplares similares